Peter Greenwald

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Cancer chemoprevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 6130 Executive Boulevard, Suite 2040, Bethesda, Maryland 20892-7309, USA
    BMJ 324:714-8. 2002
  2. ncbi Landmarks in the history of cancer epidemiology
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland, USA
    Cancer Res 69:2151-62. 2009
  3. ncbi Clinical trials of vitamin and mineral supplements for cancer prevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7309, USA
    Am J Clin Nutr 85:314S-317S. 2007
  4. ncbi Plasma proteomic profiling: search for lung cancer diagnostic and early detection markers
    Iqbal Unnisa Ali
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
    Oncol Rep 15:1367-72. 2006
  5. ncbi The future of cancer prevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 6130 Executive Blvd, Room 2040, 31 Center Dr, MSC 2580, Bethesda, MD 20892 7309, USA
    Semin Oncol Nurs 21:296-8. 2005
  6. ncbi Lifestyle and medical approaches to cancer prevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 6130 Executive Boulevard, Suite 2040, Bethesda, MD 20892 7309, USA
    Recent Results Cancer Res 166:1-15. 2005
  7. ncbi Nutritional interventions in cancer prevention
    Philip R Taylor
    National Cancer Institute, 6116 Executive Blvd, Rm 705, Bethesda, MD 20892 8314, USA
    J Clin Oncol 23:333-45. 2005
  8. ncbi Clinical trials in cancer prevention: current results and perspectives for the future
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Nutr 134:3507S-3512S. 2004
  9. ncbi Preface. The applications of bioinformatics in cancer detection
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Betheda, MD 20892-7309, USA
    Ann N Y Acad Sci 1020:ix-x. 2004
  10. ncbi Cancer prevention clinical trials
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7309, USA
    J Clin Oncol 20:14S-22S. 2002

Detail Information

Publications20

  1. ncbi Cancer chemoprevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 6130 Executive Boulevard, Suite 2040, Bethesda, Maryland 20892-7309, USA
    BMJ 324:714-8. 2002
  2. ncbi Landmarks in the history of cancer epidemiology
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland, USA
    Cancer Res 69:2151-62. 2009
    ....
  3. ncbi Clinical trials of vitamin and mineral supplements for cancer prevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7309, USA
    Am J Clin Nutr 85:314S-317S. 2007
    ....
  4. ncbi Plasma proteomic profiling: search for lung cancer diagnostic and early detection markers
    Iqbal Unnisa Ali
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
    Oncol Rep 15:1367-72. 2006
    ..Validation of these biomarkers would have significant implications for the early detection of lung cancer and better management of high-risk patients...
  5. ncbi The future of cancer prevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 6130 Executive Blvd, Room 2040, 31 Center Dr, MSC 2580, Bethesda, MD 20892 7309, USA
    Semin Oncol Nurs 21:296-8. 2005
    ..To hypothesize on the future of cancer prevention based on past and current progress of the field, as well as possible assimilation of knowledge in other fields that may be applied to cancer prevention...
  6. ncbi Lifestyle and medical approaches to cancer prevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 6130 Executive Boulevard, Suite 2040, Bethesda, MD 20892 7309, USA
    Recent Results Cancer Res 166:1-15. 2005
    ....
  7. ncbi Nutritional interventions in cancer prevention
    Philip R Taylor
    National Cancer Institute, 6116 Executive Blvd, Rm 705, Bethesda, MD 20892 8314, USA
    J Clin Oncol 23:333-45. 2005
    ....
  8. ncbi Clinical trials in cancer prevention: current results and perspectives for the future
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Nutr 134:3507S-3512S. 2004
    ....
  9. ncbi Preface. The applications of bioinformatics in cancer detection
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Betheda, MD 20892-7309, USA
    Ann N Y Acad Sci 1020:ix-x. 2004
  10. ncbi Cancer prevention clinical trials
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7309, USA
    J Clin Oncol 20:14S-22S. 2002
    ..In addition, two lifestyle factors that have potential to influence cancer risk-obesity and functionally enhanced foods-are discussed in the context of their link between clinical and public health-related research...
  11. ncbi The antioxidant conundrum in cancer
    Harold E Seifried
    Division of Cancer Prevention, National Cancer Institute NIH, 6130 Executive Boulevard, Suite 3160, Bethesda, MD 20852, USA
    Cancer Res 63:4295-8. 2003
    ..Overall, current knowledge makes it premature to generalize and make specific recommendations about antioxidant usage for those at high risk for cancer or undergoing treatment...
  12. ncbi An evidence-based approach to cancer prevention clinical trials
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, 6130 Executive Boulevard, Suite 2040, Bethesda, MD 20892 7309, USA
    Eur J Cancer Prev 11:S43-7. 2002
    ..Development of valid surrogate end point biomarkers for clinical disease that can be modulated by interventions is essential to accelerate progress in cancer prevention clinical trials...
  13. ncbi Micronutrients in cancer chemoprevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7309, USA
    Cancer Metastasis Rev 21:217-30. 2002
    ..Research priorities include investigation of possible molecular targets for micronutrients and whether genetic and epigenetic events dictate direction and magnitude of the response...
  14. ncbi Beta-carotene and lung cancer: a lesson for future chemoprevention investigations?
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Natl Cancer Inst 95:E1. 2003
  15. ncbi A favorable view: progress in cancer prevention and screening
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7309, USA
    Recent Results Cancer Res 174:3-17. 2007
    ..If these biomarkers can be validated, they might help to reduce cancer mortality...
  16. ncbi Serum proteomic profiles suggest celecoxib-modulated targets and response predictors
    Zhen Xiao
    Laboratory of Proteomics and Analytical Technologies and Advanced Biomedical Computing Center, SAIC-Frederick Inc, National Cancer Institute at Frederick, Frederick, Maryland, USA
    Cancer Res 64:2904-9. 2004
    ..In particular, a spectral feature at m/z 16,961.4 was identified as a strong discriminator between response and nonresponse to celecoxib at the highest dose...
  17. ncbi Biomarkers for early detection and as surrogate endpoints in cancer prevention trials: issues and opportunities
    Barbara K Dunn
    Basic Prevention Science Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892 7340, USA
    Recent Results Cancer Res 188:21-47. 2011
    ....
  18. ncbi Future directions in cancer prevention
    Asad Umar
    National Cancer Institute, Division of Cancer Prevention, Gastrointestinal and Other Cancers Research Group, National Cancer Institute, Executive Plaza North 2142, 6130 Executive Boulevard, MSC 7317, Rockville, Maryland 20852 7371, USA
    Nat Rev Cancer 12:835-48. 2012
    ....
  19. ncbi Do we make optimal use of the potential of cancer prevention?
    Peter Greenwald
    National Cancer Institute NIH, Division of Cancer Prevention, Bethesda, MD 20892, USA
    Recent Results Cancer Res 181:3-17. 2009
    ..Training current researchers in new approaches will add efficiency to their combined research experiences...
  20. ncbi Molecular markers for early detection
    Barbara K Dunn
    National Cancer Institute, Division of Cancer Prevention, Bethesda, MD 20892 7340, USA
    Semin Oncol 37:224-42. 2010
    ....